Effective Label-Free Sorting of Multipotent Mesenchymal Stem Cells from Clinical Bone Marrow Samples

Area of Science:

• Biotechnology
• Regenerative Medicine
• Cell Biology

Background:

• Mesenchymal stem cells (MSCs) constitute a small fraction of bone marrow (BM).
• Current isolation methods like gradient separation or centrifugation are indirect, requiring further steps such as plastic adherence or cell sorting.
• These existing techniques can alter native cell properties.

Purpose of the Study:

• To investigate a new label-free separative technology for isolating MSCs from BM.
• To assess if the technology preserves native cell physical properties and allows real-time visualization.
• To evaluate the isolated cell fractions for MSC characteristics.

Main Methods:

• Utilized a novel label-free technology to separate cells based on physical characteristics.
• Analyzed fresh BM from patients with osteochondral defects directly in the operating room.
• Collected and evaluated three distinct cell fractions (F1, F2, F3) for morphology, phenotype, CFU-F, and differentiation potential.

Main Results:

• Identified multipotent MSCs predominantly in fraction F1.
• Fraction F1 exhibited higher colony-forming unit-fibroblast (CFU-F) activity and differentiation potential.
• The technology effectively depleted dead cells, red blood cells, and non-progenitor stromal cells.

Conclusions:

• The new technology offers an effective, direct method for isolating MSCs from fresh BM.
• It preserves the native characteristics of MSCs by avoiding cell manipulation.
• This approach has potential applications in orthopedic regenerative medicine and clinical settings.